Evidence map›Paper›PMID 31561032›Full record

ArticleHeart rhythm2020

Complications involving the subcutaneous implantable cardioverter-defibrillator: Lessons learned from MAUDE.

Emily P Zeitler, Daniel J Friedman, Zak Loring, Kristen B Campbell, Sarah A Goldstein, Zachary K Wegermann, Jane Schutz, Nicole Smith, Eric Black-Maier, Sana M Al-Khatib and 1 more

Abstract read
In one paragraph

Article in Heart rhythm, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Air entrapment as a potential cause of early subcutaneous implantable cardioverter defibrillator malfunction: a systematic review of the literature.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2022
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Eligibility for subcutaneous implantable cardioverter-defibrillator in patients with left ventricular assist device.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2021
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Emily P ZeitlerDivision of Cardiology, The Geisel School of Medicine at Dartmouth, Hanover, New Hampshire; Division of Cardiology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire; Division of Cardiology, The Dartmouth Institute, Lebanon, New Hampshire. Electronic address: emily.p.zeitler@hitchcock.org.
Daniel J FriedmanDivision of Cardiology, Duke University Hospital, Durham, North Carolina.
Zak LoringDivision of Cardiology, Duke University Hospital, Durham, North Carolina; Division of Cardiology, The Duke Clinical Research Institute, Durham, North Carolina.
Kristen B CampbellDivision of Cardiology, Duke University Hospital, Durham, North Carolina.
Sarah A GoldsteinDivision of Cardiology, Duke University Hospital, Durham, North Carolina.
Zachary K WegermannDivision of Cardiology, Duke University Hospital, Durham, North Carolina.
Jane SchutzDivision of Cardiology, Duke University Hospital, Durham, North Carolina.
Nicole SmithDivision of Cardiology, Duke University Hospital, Durham, North Carolina.
Eric Black-MaierDivision of Cardiology, Duke University Hospital, Durham, North Carolina.
Sana M Al-KhatibDivision of Cardiology, Duke University Hospital, Durham, North Carolina; Division of Cardiology, The Duke Clinical Research Institute, Durham, North Carolina.
Jonathan P PicciniDivision of Cardiology, Duke University Hospital, Durham, North Carolina; Division of Cardiology, The Duke Clinical Research Institute, Durham, North Carolina.

Funding

Postdoctoral Training in Cardiovascular Clinical ResearchT32HL069749 · NHLBI · DUKE UNIVERSITY · PI MARK, DANIEL B · 2003 to 2023
$6.7M
NHLBI NIH HHS T32 HL069749
6 · The paper itself

Abstract

backgroundReports on the subcutaneous implantable cardioverter-defibrillator (S-ICD) cumulatively demonstrate a low rate of complications, but clinical experience with this technology is limited compared with transvenous devices.

objectiveThe purpose of this study was to describe and analyze S-ICD complications reported to the Food and Drug Administration's Manufacturer and User Facility Device Experience database.

methodsWe reviewed all S-ICD events reported to the Manufacturer and User Facility Device Experience submitted over 24 months (from February 2016 through February 2018) through a prospective and standardized approach at a time when an estimated 15,000 S-ICDs were in service.

resultsAfter removing duplicate entries and nonclinical events (n = 493), 1604 events remained. A total of 542 instances of infection were reported with system removal in 414/542 (77.5%). Inappropriate shocks occurred in 550 patients, and 382 (69%) were attributed to oversensing; in response, 254 (56%), 147 (33%), and 80 (18%) patients underwent system reprogramming, removal, or revision, respectively. There were 15 deaths, and causes included defibrillation failure during follow-up (n = 2), ventricular fibrillation induced by the device (n = 4), device-device interaction resulting in undersensing (n = 1), procedure-related complications (n = 4), and uncertain etiology (n = 4). There were 137 reports of system migration, and in 57 (42%) of these, there were associated inappropriate shocks. System migration events were managed with a combination of system revision (69 [51%]), reprogramming (25 [18%]), and system removal (44 [32%]).

conclusionSeveral S-ICD complications have been reported that appear to be related to the ICD's design and function over time. A better understanding of these complications may help inform patient selection, implant technique, and postimplantation management.

Indexed as

Arrhythmias, CardiacCause of DeathDeath, Sudden, CardiacDefibrillators, ImplantableEquipment FailureFemaleHumansMaleRetrospective StudiesSurvival RateTreatment OutcomeUnited StatesComplicationsImplantable cardioverter-defibrillatorMAUDEMortalitySubcutaneous ICD

Identifiers

PMID31561032
PMCPMC7519585

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.